Bio-Gene Technology Limited
BGT.AX
Price:
$0.026
Market Cap:
$7.93M
Bio-Gene Technology Limited, an agtech development company, engages in developing and commercializing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. Its lead products include Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from a cultivar of eucalyptus cloeziana. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production. It also has research collaborations with BASF, Grains Research and Development Corporation, and Queensland Department...[Read more]
Industry
Biotechnology
IPO Date
2017-11-28
Stock Exchange
ASX
Ticker
BGT.AX
PE Ratio
[-2.60]
ROE
[-137.10%]
Current Ratio
[3.86]
Dividend Yield
[0%]
Enterprise Value
[6.84M]
Dividend History
The ROE as of December 2025 (TTM) for Bio-Gene Technology Limited (BGT.AX) is -137.10%
According to Bio-Gene Technology Limited’s latest financial reports and current stock price. The company's current ROE is -137.10%. This represents a change of 151.60% compared to the average of -54.49% of the last 4 quarters.
Bio-Gene Technology Limited (BGT.AX) Historical ROE (quarterly & annually)
How has BGT.AX ROE performed in the past?
The mean historical ROE of Bio-Gene Technology Limited over the last ten years is -63.60%. The current -137.10% ROE has changed 115.59% with respect to the historical average. Over the past ten years (40 quarters), BGT.AX's ROE was at its highest in in the December 2013 quarter at 0%. The ROE was at its lowest in in the December 2024 quarter at -110.43%.
Average
-63.60%
Median
-51.46%
Minimum
-158.85%
Maximum
-11.63%
Bio-Gene Technology Limited (BGT.AX) ROE by Quarter and Year
Discovering the peaks and valleys of Bio-Gene Technology Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 252.71%
Maximum Annual ROE = -11.63%
Minimum Annual Increase = -82.93%
Minimum Annual ROE = -158.85%
| Year | ROE | Change |
|---|---|---|
| 2025 | -158.85% | 84.03% |
| 2024 | -86.32% | -10.18% |
| 2023 | -96.10% | 106.72% |
| 2022 | -46.49% | -17.62% |
| 2021 | -56.43% | 75.23% |
| 2020 | -32.21% | -16.97% |
| 2019 | -38.79% | -5.43% |
| 2018 | -41.02% | 252.71% |
| 2017 | -11.63% | -82.93% |
| 2016 | -68.14% | 201.88% |
Bio-Gene Technology Limited (BGT.AX) Average ROE
How has BGT.AX ROE performed in the past?
The current ROE of Bio-Gene Technology Limited (BGT.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-113.75%
5-year avg
-88.84%
10-year avg
-63.60%
Bio-Gene Technology Limited (BGT.AX) ROE vs. Peers
How is BGT.AX’s ROE compared to its peers?
Bio-Gene Technology Limited’s ROE is greater than Invex Therapeutics Ltd (-8.98%), greater than Vectus Biosystems Limited (-2425.76%), greater than Intelicare Holdings Limited (-1086.20%), greater than Memphasys Limited (-86.37%), greater than Percheron Therapeutics Limited (-117.98%), greater than Acrux Limited (-268.28%), greater than Biotron Limited (-63.03%), greater than Chimeric Therapeutics Limited (-167.90%), less than InhaleRx Limited (296.01%), greater than Cann Group Limited (-1259.94%),
| Company | ROE | Market cap |
|---|---|---|
| -8.98% | $9.02M | |
| -2425.76% | $5.87M | |
| -1086.20% | $10.52M | |
| -86.37% | $9.82M | |
| -117.98% | $7.61M | |
| -268.28% | $6.57M | |
| -63.03% | $4.98M | |
| -167.90% | $12.75M | |
| 296.01% | $5.49M | |
| -1259.94% | $5.63M |
Build a custom stock screener for Bio-Gene Technology Limited (BGT.AX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Gene Technology Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Bio-Gene Technology Limited (BGT.AX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Bio-Gene Technology Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Bio-Gene Technology Limited's ROE?
How is the ROE calculated for Bio-Gene Technology Limited (BGT.AX)?
What is the highest ROE for Bio-Gene Technology Limited (BGT.AX)?
What is the 3-year average ROE for Bio-Gene Technology Limited (BGT.AX)?
What is the 5-year average ROE for Bio-Gene Technology Limited (BGT.AX)?
How does the current ROE for Bio-Gene Technology Limited (BGT.AX) compare to its historical average?